MS Lemtrada

Lemtrada (also known as alemtuzumab or campath) is a disease modifying treatment (DMT) for highly active relapsing remitting multiple sclerosis. Lemtrada is given as an intravenous infusion (drip), often in two treatment courses, twelve months apart. Clinical trials have shown that Lemtrada reduces relapses by around 50% compared to a placebo.

Ask the community your questions about Lemtrada or read about other people's Lemtrada MS experiences.

949 conversations about Lemtrada

2 videos about Lemtrada